I last reviewed the First Trust Rising Dividend Achievers ETF ( RDVY ) on October 19, 2023, when I rated it a "sell" based on the flat expected earnings growth of its constituents and underwhelming quality features. However, this updateThe Sunday Investor is focused exclusively on U.S. Equity ETFs. He has a strong analytical background, has received a Certificate of Advanced Investment Advice from the Canadian Securities Institute, and has completed all the educational requirements for the Chartered Investm ...

Core Viewpoint - The recommendation for iShares Core High Dividend ETF (HDV) is to maintain a "Hold" position due to geopolitical uncertainty and significant government influence in the market [1] Summary by Relevant Categories Investment Recommendation - A "Hold" recommendation is suggested for HDV to ensure quality stocks are retained in the portfolio during uncertain times [1] Market Conditions - The current market is characterized by geopolitical uncertainty and notable government influence, which impacts investment strategies [1]

Core Insights - Visa Inc. is a global leader in digital payments, known for its credit and debit card services, and is expanding its digital offerings to adapt to the evolving financial landscape [1] Financial Performance - Visa reported a 15% year-over-year increase in net revenue, reaching $10.9 billion for the quarter ending December 31 [3][6] - The company's adjusted net income rose by 12% to $6.1 billion, with adjusted earnings per share climbing 15% to $3.17, surpassing Wall Street's expectations of $3.14 [4][6] Market Position - Visa's stock has experienced a positive change of $12.01, reflecting a 3.73% increase, with a market capitalization of approximately $643.66 billion [5] - The total number of transactions processed on Visa's network surged by 9% to 69.4 billion [3] International Operations - International operations have shown significant strength, with cross-border volumes increasing by 12% [4] Analyst Outlook - Daiwa set a price target of $370 for Visa, indicating a potential increase of 10.83% from its current trading price of $333.84, supported by Visa's recent performance [2][6]

Core Viewpoint - Peakstone Realty Trust (PKST) is undergoing significant changes with a downgrade from UBS and an acquisition by Brookfield Asset Management [1][5]. Group 1: Company Developments - UBS downgraded PKST from an "Outperform" rating to a "Neutral" rating, with the stock priced at $20.77 at the time of the downgrade [1][5]. - Brookfield Asset Management has announced a definitive agreement to acquire PKST in an all-cash transaction valued at $1.2 billion, purchasing all outstanding shares at $21.00 per share, which is a premium over the current stock price [2]. Group 2: Stock Performance - Despite the downgrade, PKST's stock has increased by 32.97%, with a change of $5.15, and has fluctuated between a low of $20.67 and a high of $20.85 today, marking its highest price over the past year [3]. - The lowest price for PKST in the past year was $10.35, indicating significant growth [3]. Group 3: Market Position - PKST has a market capitalization of approximately $764.1 million, reflecting its position in the industrial real estate sector [4]. - The trading volume for PKST today is 10,040,104 shares on the NYSE, highlighting strong investor interest [4].

If you don't mind boring stocks, this trio of high yielders could be solid income picks in 2026.Oil and natural gas are highly volatile commodities. That makes the energy sector fairly volatile, too. However, if you dig beneath the surface just a little, you'll see that all energy stocks aren't built the same way. Here are three midstream businesses you'll want to look at in 2026 that offer high yields and are backed by boring, fee-generating businesses.The midstream is built for dividend investorsUpstream ...

Core Viewpoint - Northfield Bancorp, Inc. reported disappointing earnings per share (EPS) of -$0.69, significantly below the estimated EPS of $0.28, despite generating revenue of approximately $41.3 million, which exceeded the estimated revenue of about $39.5 million [1][2][6] Financial Performance - The company experienced a net loss of $27.4 million for the fourth quarter of 2025, primarily due to a $41 million goodwill impairment charge [2] - The goodwill impairment charge was $1.03 per share, non-cash, and non-tax deductible, leaving Northfield Bancorp with no remaining goodwill [3] - In the previous quarter, the company reported a net income of $10.8 million, or $0.27 per diluted share [3] Strategic Developments - Northfield Bancorp announced a merger with Columbia Financial, Inc., which is expected to enhance their market position [4][6] - The company declared a cash dividend of $0.13 per share, payable on February 25, 2026, to stockholders of record as of February 12, 2026 [4] Financial Metrics - Northfield Bancorp's financial metrics include a price-to-sales ratio of about 2.21, an enterprise value to sales ratio of around 2.16, and an enterprise value to operating cash flow ratio of approximately 12.98 [5]

Anthropic's sales are set to skyrocket in 2026 and beyond, and these two hardware companies are helping to make it possible.Anthropic is still a private company, but some reports and speculation suggest that it could have its initial public offering (IPO) this year. Despite the company still being private, reports have surfaced surrounding the company's sales outlook for this year. According to reports, the artificial intelligence (AI) company and Claude parent now expects its sales to reach roughly $18 bil ...

Core Insights - Valneva SE and Instituto Butantan have initiated a Pilot Vaccination Strategy (PVS) in Brazil for Valneva's chikungunya vaccine, IXCHIQ®, aimed at generating real-world evidence on its effectiveness and safety [1][2] Group 1: Pilot Vaccination Strategy - The PVS will be implemented in ten Brazilian municipalities selected based on epidemiological and operational criteria, targeting adults aged 18 to 59 years with a goal of achieving 20% to 40% vaccine coverage [2] - Valneva will donate up to 500,000 doses of IXCHIQ® to the Brazilian Ministry of Health for the program [2] - IXCHIQ® received marketing approval in Brazil in April 2025, marking the first approval of a chikungunya vaccine in an endemic country [2] Group 2: Public Health Context - Brazil has reported over one million chikungunya cases from January 2019 to July 2024, including 263,502 cases in 2024, resulting in 246 deaths [3] - The World Health Organization has called for urgent action to prevent a potential major chikungunya epidemic globally [3] Group 3: Collaboration and Support - Valneva and Instituto Butantan signed an agreement in January 2021 for the technology transfer of the chikungunya vaccine, which will be developed and commercialized in Latin America [4] - This collaboration is supported by the Coalition for Epidemic Preparedness Innovations (CEPI) and the European Union [4]

Agreement adds up to five years and five additional Boeing 777F aircraft to the program SINGAPORE, Feb. 3, 2026 /PRNewswire/ -- Collins Aerospace, an RTX business (NYSE: RTX), has signed an agreement to extend the FlightSenseâ"¢ services with Singapore Airlines for its Boeing 777 fleet. The agreement provides for five additional years and will cover a total of 27 aircraft, including five Boeing 777F aircraft that have been added to the program. The FlightSense service relationship with Singapore Airlines st ...

TEMPE, Ariz. and PRAGUE, Feb. 3, 2026 /PRNewswire/ -- Avast, a leader in digital security and privacy and part of Gen (NASDAQ: GEN), today announced the full international availability of Avast Scam Guardian and Scam Guardian Pro on mobile devices, alongside the launch of Avast Deepfake Guard on Windows PCs, a new AI-powered feature designed to proactively analyze and detect malicious audio in video content. Together, these launches mark a significant expansion of the Avast scam protection ecosystem – exten ...